$467.73
-5.46-1.15%
Last update: Nov 3, 4:47 AM
HCA Healthcare Inc
HCANYSE
HCA Healthcare (HCA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
HCA Healthcare (HCA) last issued guidance on October 27, 2026 for fiscal year 2026. The company guided earnings per share in the range of $29.6 - $30.5, compared to a consensus EPS estimate of $29.48. HCA Healthcare also guided revenue in the range of $78.25B - $79.5B for the period.
Compared to prior guidance, HCA Healthcare raised its EPS outlook from a previous range of $28.7 - $30.5. On the revenue side, the company maintained its revenue forecast from a prior range of $77B - $79.5B.
HCA Healthcare has issued 18 guidance updates between January 27, 2023 and October 27, 2026. During this period, the company raised its outlook 9 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.65 | $7.41 | $7.16 | $7.42 |
| Actual | $7.22 | $7.59 | $7.15 | $8.01 |
| Surprise | +8.57% | +2.43% | -0.14% | +7.95% |
| Revenue | ||||
| Estimate | $19.33B | $19.37B | $19.07B | $19.66B |
| Actual | $19.85B | $20.23B | $19.11B | $19.51B |
| Surprise | +2.68% | +4.43% | +0.19% | -0.74% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $8.18 | $7.56 | $7.77 | $7.53 |
| Revenue | ||||
| Consensus | $20.01B | $19.88B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $7.22 | $6.65 | 8.57 % |
| Q2 | Jul 24, 2026 | $7.59 | $7.41 | 2.43 % |
| Q1 | Apr 24, 2026 | $7.15 | $7.16 | -0.14 % |
| Q4 | Jan 27, 2026 | $8.01 | $7.42 | 7.95 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $19.85B | $19.33B | 2.68 % |
| Q2 | Jul 24, 2026 | $20.23B | $19.37B | 4.43 % |
| Q1 | Apr 24, 2026 | $19.11B | $19.07B | 0.19 % |
| Q4 | Jan 27, 2026 | $19.51B | $19.66B | -0.74 % |
